HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Difference in distant failure site between locally advanced squamous cell carcinoma and adenocarcinoma of the uterine cervix after C-ion RT.

Abstract
We investigated the first site of distant failure after carbon ion radiotherapy (C-ion RT) for locally advanced cervical cancer in three clinical trials. A total of 91 cases were enrolled in the three trials (Protocol 9702, 9704 and 9902). Histologically, 36 cases had squamous cell carcinoma (SqCC) and 55 cases had adenocarcinoma (AC), including 13 with adenosquamous cell carcinoma. The number of cases with Stage IIB, IIIB and IVA disease was 21, 59 and 11, respectively. Of the 91 cases, 42 had positive pelvic lymph nodes (PLNs). The median tumor size was 6.0 cm (range, 3.0–12.0 cm). The median follow-up duration for all cases was 40 months (range, 7–181 months). A total of 40 cases developed distant failure as the first site of failure: 13 of 36 (36.1%) SqCC cases had distant failure, with 9 of them with para-aortic lymph node (PALN) failure; 27 of 55 (44.0%) AC cases had distant failure, and 23 of them had distant failure excluding PALN metastasis. Distant failure rates of SqCC cases who had positive and negative PLNs before C-ion RT were 61.1% and 11.1%, respectively (P = 0.0045). Those of AC cases were 54.2% and 45.2%, respectively (P = 0.507). In conclusion, there were high rates of distant failure after C-ion RT in AC cases regardless of PLN status, and there were high rates of distant failure after C-ion RT, especially PALN failure, in SqCC cases with positive PLNs.
AuthorsMasaru Wakatsuki, Shingo Kato, Tatsuya Ohno, Hiroki Kiyohara, Kumiko Karasawa, Tomoaki Tamaki, Ken Ando, Daisuke Irie, Shintaro Shiba, Hirohiko Tsujii, Takashi Nakano, Tadashi Kamada, Makio Shozu, Working Group of the Gynecological Tumor
JournalJournal of radiation research (J Radiat Res) Vol. 56 Issue 3 Pg. 523-8 (May 2015) ISSN: 1349-9157 [Electronic] England
PMID25589503 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adenocarcinoma (pathology, radiotherapy, secondary)
  • Aged
  • Carcinoma, Squamous Cell (pathology, radiotherapy, secondary)
  • Female
  • Heavy Ion Radiotherapy (methods)
  • Humans
  • Middle Aged
  • Radiotherapy Dosage
  • Treatment Failure
  • Treatment Outcome
  • Uterine Neoplasms (pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: